Evidence map›Paper›PMID 41881906›Full record

ReviewHuman immunology2026

Next-Generation regulatory T cell therapies: Translational considerations for inflammatory bowel disease.

Michelle M Gonzalez, Gloria B Kim, Mohsen Khosravi Maharlooei, Sameena Nikhat, Feda H Hamdan, Michael P Gustafson, William A Faubion

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Human immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michelle M GonzalezDepartment of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, AZ, USA. Electronic address: gonzalez.michelle@mayo.edu.
Gloria B KimDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Scottsdale, AZ, USA; Department of Immunology, Mayo Clinic, Phoenix, AZ, USA.
Mohsen Khosravi MaharlooeiDepartment of Immunology, Mayo Clinic, Phoenix, AZ, USA; Department of Biochemistry and Molecular Biology, Mayo Clinic, Phoenix, AZ, USA.
Sameena NikhatDepartment of Immunology, Mayo Clinic, Phoenix, AZ, USA.
Feda H HamdanDepartment of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, AZ, USA; Department of Biochemistry and Molecular Biology, Mayo Clinic, Phoenix, AZ, USA.
Michael P GustafsonDepartment of Immunology, Mayo Clinic, Phoenix, AZ, USA; Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ, USA.
William A FaubionDepartment of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, AZ, USA; Department of Immunology, Mayo Clinic, Phoenix, AZ, USA.

Funding

Aging lymphocytes: senescence programs in lymphocytes relevant to human inflammatory bowel diseaseK08DK134759 · NIDDK · MAYO CLINIC ROCHESTER · PI Michelle M Gonzalez Salgado · 2023 to 2026
$654k
NIDDK NIH HHS K08 DK134759
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41881906
PMCPMC13614616

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.